20 Chapter 1 References 1. Dorsey K, Agulnik M. Promising new molecular targeted therapies in head and neck cancer. Drugs 2013;73:315-25. 2. Ferlay J, Ervik M, Lam F, Colombet M, Mery L, Piñeros M, et al. Global Cancer Observatory: Cancer Today. https:// gco.iarc.fr/today. 2020. Accessed: 10.06.2021 2021. 3. Leemans CR, Snijders PJF, Brakenhoff RH. The molecular landscape of head and neck cancer. Nat Rev Cancer 2018;18:269-82. 4. SEER. Cancer Statistics Review (CSR) 1975 - 2018. https://seer.cancer.gov/csr/1975_2018/. Accessed: 10.06.2021 2021. 5. Chinn SB, Myers JN. Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions. J Clin Oncol 2015;33:3269-76. 6. Surveillance Research Program. SEER*Explorer: An interactive website for SEER cancer statistics. https://seer. cancer.gov/explorer/. Accessed: 08.12.2021 2021. 7. Institute NC. Surveillance, Epidemiology, and End Results Program Summary Stage 2018. https://seer.cancer. gov/tools/ssm/. 2018. 2022. 8. SEER. SEER Training Modules Summary Staging. https://training.seer.cancer.gov/staging/systems/summary/. Accessed: 08.12.2021 2021. 9. Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma. Nat Rev Dis Primers 2020;6:92. 10. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011;11:9-22. 11. Network NCC. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Head and Neck Cancers Version 2.2020. https://www.nccn.org/. 2020. 2020. 12. Dhar H, Vaish R, D’Cruz AK. Management of locally advanced oral cancers. Oral Oncol 2020;105:104662. 13. Almangush A, Makitie AA, Triantafyllou A, de Bree R, Strojan P, Rinaldo A, et al. Staging and grading of oral squamous cell carcinoma: An update. Oral Oncol 2020;107:104799. 14. AJCC. Cancer staging 7th edition. 15. AJCC. Cancer staging 8th edition. 16. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945-52. 17. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937-44. 18. Jain PV, Sharan R, Manikantan K, Clark GM, Chatterjee S, Mallick I, et al. Redefining adequate margins in oral squamous cell carcinoma: outcomes from close and positive margins. Eur Arch Otorhinolaryngol 2020;277:1155-65. 19. Loree TR, Strong EW. Significance of positive margins in oral cavity squamous carcinoma. Am J Surg 1990;160:410-4. 20. Smits RWH, van Lanschot CGF, Aaboubout Y, de Ridder M, Hegt VN, Barroso EM, et al. Intraoperative Assessment of the Resection Specimen Facilitates Achievement of Adequate Margins in Oral Carcinoma. Front Oncol 2020;10:614593. 21. Brouwer de Koning SG, Schaeffers A, Schats W, van den Brekel MWM, Ruers TJM, Karakullukcu MB. Assessment of the deep resection margin during oral cancer surgery: A systematic review. Eur J Surg Oncol 2021.
RkJQdWJsaXNoZXIy MTk4NDMw